High-dose supplements of vitamins C and E, low-dose multivitamins, and the risk of age-related cataract: A population-based prospective cohort study of men

American Journal of Epidemiology

Volumn 177, Issue 6, 2013, Pages 548-555

  Zheng Selin, Jinjin ^a   Rautiainen, Susanne ^a,b   Lindblad, Birgitta Ejdervik ^a,c,d   Morgenstern, Ralf ^a   Wolk, Alicja ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^d ÖREBRO UNIVERSITY   (Sweden)

Author keywords

ascorbic acid; cataract; dietary supplements; oxidative stress; vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CORTICOSTEROID; REACTIVE OXYGEN METABOLITE;

COHORT ANALYSIS; DISEASE INCIDENCE; HEALTH RISK; HEALTH STATUS; MALE; MENS HEALTH; QUESTIONNAIRE SURVEY; VITAMIN;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; SENILE CATARACT; SMOKING; VITAMIN SUPPLEMENTATION;

ADRENAL CORTEX HORMONES; AGE FACTORS; AGED; ALCOHOL DRINKING; ASCORBIC ACID; CATARACT; DIET; DIETARY SUPPLEMENTS; EDUCATIONAL STATUS; HUMANS; INCIDENCE; LIFE STYLE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SMOKING; SWEDEN; VITAMIN E; VITAMINS; WAIST CIRCUMFERENCE;

SWEDEN;

EID: 84874886631     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws279     Document Type: Article

References (51)

1. Lin J, Cook NR, Albert C, et al. Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J Natl Cancer Inst. 2009;101(1):14-23.
2. Sesso HD, Buring JE, Christen WG, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2008;300(18):2123-2133.
3. Mursu J, Robien K, Harnack LJ, et al. Dietary supplements and mortality rate in older women: the Iowa Women's Health Study. Arch Intern Med. 2011;171(18):1625-1633.
4. Bjelakovic G, Nikolova D, Gluud LL, et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297(8):842-857.
5. Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005;293(11):1338-1347.
6. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994;330(15):1029-1035.
7. Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306(14): 1549-1556.
8. Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst. 1996;88(21):1550-1559.
9. Shichi H. Cataract formation and prevention. Expert Opin Investig Drugs. 2004;13(6):691-701.
10. Lou MF. Redox regulation in the lens. Prog Retin Eye Res. 2003;22(5):657-682.
11. Christen WG, Glynn RJ, Sesso HD, et al. Age-related cataract in a randomized trial of vitamins E and C in men. Arch Ophthalmol-Chic. 2010;128(11):1397-1405.
12. Christen WG, Glynn RJ, Chew EY, et al. Vitamin E and agerelated cataract in a randomized trial of women. Ophthalmology. 2008;115(5):822-829.
13. McNeil JJ, Robman L, Tikellis G, et al. Vitamin E supplementation and cataract: randomized controlled trial. Ophthalmology. 2004;111(1):75-84.
14. AREDS Study. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001;119(10):1439-1452.
15. Teikari JM, Rautalahti M, Haukka J, et al. Incidence of cataract operations in Finnish male smokers unaffected by alpha tocopherol or beta carotene supplements. J Epidemiol Community Health. 1998;52(7):468-472.
16. Gritz DC, Srinivasan M, Smith SD, et al. The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India. Br J Ophthalmol. 2006;90(7):847-851.
17. Chylack LT Jr, Brown NP, Bron A, et al. The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol. 2002;9(1):49-80.
18. Sperduto RD, Hu TS, Milton RC, et al. The Linxian cataract studies. Two nutrition intervention trials. Arch Ophthalmol. 1993;111(9):1246-1253.
19. Rautiainen S, Lindblad BE, Morgenstern R, et al. Vitamin C supplements and the risk of age-related cataract: a populationbased prospective cohort study in women. Am J Clin Nutr. 2010;91(2):487-493.
20. Chasan-Taber L, Willett WC, Seddon JM, et al. A prospective study of vitamin supplement intake and cataract extraction among U.S. women. Epidemiology. 1999;10(6):679-684.
21. Taylor A, Jacques PF, Chylack LT Jr, et al. Long-term intake of vitamins and carotenoids and odds of early age-related cortical and posterior subcapsular lens opacities. Am J Clin Nutr. 2002;75(3):540-549.
22. Jacques PF, Chylack LT Jr, Hankinson SE, et al. Long-term nutrient intake and early age-related nuclear lens opacities. Arch Ophthalmol. 2001;119(7):1009-1019.
23. Klein BE, Knudtson MD, Lee KE, et al. Supplements and age-related eye conditions: the Beaver Dam Eye Study. Ophthalmology. 2008;115(7):1203-1208.
24. Leske MC, Chylack LT Jr, He Q, et al. Antioxidant vitamins and nuclear opacities: the longitudinal study of cataract. Ophthalmology. 1998;105(5):831-836.
25. Mares-Perlman JA, Lyle BJ, Klein R, et al. Vitamin supplement use and incident cataracts in a population-based study. Arch Ophthalmol. 2000;118(11):1556-1563.
26. Seddon JM, Christen WG, Manson JE, et al. The use of vitamin supplements and the risk of cataract among US male physicians. Am J Public Health. 1994;84(5):788-792.
27. van Haaften RI, Haenen GR, van Bladeren PJ, et al. Inhibition of various glutathione S-transferase isoenzymes by RRRalpha-tocopherol. Toxicol In Vitro. 2003;17(3):245-251.
28. Cheng R, Lin B, Lee KW, et al. Similarity of the yellow chromophores isolated from human cataracts with those from ascorbic acid-modified calf lens proteins: evidence for ascorbic acid glycation during cataract formation. Biochim Biophys Acta. 2001;1537(1):14-26.
29. Cheng R, Feng Q, Ortwerth BJ. LC-MS display of the total modified amino acids in cataract lens proteins and in lens proteins glycated by ascorbic acid in vitro. Biochim Biophys Acta. 2006;1762(5):533-543.
30. Linetsky M, Shipova E, Cheng R, et al. Glycation by ascorbic acid oxidation products leads to the aggregation of lens proteins. Biochim Biophys Acta. 2008;1782(1):22-34.
31. Linetsky M, James HL, Ortwerth BJ. Spontaneous generation of superoxide anion by human lens proteins and by calf lens proteins ascorbylated in vitro. Exp Eye Res. 1999;69(2): 239-248.
32. Holmquist C, Larsson S, Wolk A, et al. Multivitamin supplements are inversely associated with risk of myocardial infarction in men and women-Stockholm Heart Epidemiology Program (SHEEP). J Nutr. 2003;133(8): 2650-2654.
33. Messerer M, Wolk A. Sensitivity and specificity of selfreported use of dietary supplements. Eur J Clin Nutr. 2004; 58(12):1669-1671.
34. Bergstrom L, Kylberg E, Hagman U, et al. The food composition database KOST: the National Administration's Information system for nutritive values of food. Var Foda. 1991;43:439-447.
35. Willett W, Stampfer MJ. Total energy-intake-implications for epidemiologic analyses. Am J Epidemiol. 1986;124(1): 17-27.
36. Nationella Kataraktregistret [in Swedish]. Karlskrona, Sweden: Eye-Net Sweden; 2008. (http://www.cataractreg.com/Cataract-Sve/forstasida.htm). (Accessed November 1, 2011).
37. Cox DR. Regression models and life tables (with discussion). J R Stat Soc (B). 1972;34(2):187-220.
38. Orsini N, Bellocco R, Bottai M, et al. A tool for deterministic and probabilistic sensitivity analysis of epidemiologic studies. Stata J. 2008;8(1):29-48.
39. Assmann SF, Hosmer DW, Lemeshow S, et al. Confidence intervals for measures of interaction. Epidemiology. 1996; 7(3):286-290.
40. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
41. Chiu CJ, Taylor A. Nutritional antioxidants and age-related cataract and maculopathy. Exp Eye Res. 2007;84(2):229-245.
42. Shang F, Lu M, Dudek E, et al. Vitamin C and vitamin E restore the resistance of GSH-depleted lens cells to H2O2. Free Radic Biol Med. 2003;34(5):521-530.
43. Truscott RJ. Age-related nuclear cataract-oxidation is the key. Exp Eye Res. 2005;80(5):709-725.
44. Taylor A, Jacques PF, Nowell T, et al. Vitamin C in human and guinea pig aqueous, lens and plasma in relation to intake. Curr Eye Res. 1997;16(9):857-864.
45. Bowry VW, Stocker R. Tocopherol-mediated peroxidation-the prooxidant effect of vitamin-E on the radical-initiated oxidation of human low-density-lipoprotein. J Am Chem Soc. 1993;115(14):6029-6044.
46. Huang HY, Appel LJ. Supplementation of diets with alphatocopherol reduces serum concentrations of gamma-and delta-tocopherol in humans. J Nutr. 2003;133(10): 3137-3140.
47. Krepler K, Schmid R. Alpha-tocopherol in plasma, red blood cells and lenses with and without cataract. Am J Ophthalmol. 2005;139(2):266-270.
48. Ferrigno L, Aldigeri R, Rosmini F, et al. Associations between plasma levels of vitamins and cataract in the Italian-American Clinical Trial of Nutritional Supplements and Age-Related Cataract (CTNS): CTNS Report #2. Ophthalmic Epidemiol. 2005;12(2):71-80.
49. Schaumberg DA, Ridker PM, Glynn RJ, et al. High levels of plasma C-reactive protein and future risk of age-related cataract. Ann Epidemiol. 1999;9(3):166-171.
50. Cumming RG, Mitchell P. Inhaled corticosteroids and cataract: prevalence, prevention and management. Drug Saf. 1999;20(1):77-84.
51. Urban RC Jr, Cotlier E. Corticosteroid-induced cataracts. Surv Ophthalmol. 1986;31(2):102-110.